Author
Listed:
- Norbert Pardi
(Perelman School of Medicine, University of Pennsylvania)
- Michael J. Hogan
(Perelman School of Medicine, University of Pennsylvania)
- Rebecca S. Pelc
(Viral Pathogenesis Section, National Institute of Allergy and Infectious Disease, National Institutes of Health)
- Hiromi Muramatsu
(Perelman School of Medicine, University of Pennsylvania)
- Hanne Andersen
(Bioqual Inc.)
- Christina R. DeMaso
(Viral Pathogenesis Section, National Institute of Allergy and Infectious Disease, National Institutes of Health)
- Kimberly A. Dowd
(Viral Pathogenesis Section, National Institute of Allergy and Infectious Disease, National Institutes of Health)
- Laura L. Sutherland
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Richard M. Scearce
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Robert Parks
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Wendeline Wagner
(Bioqual Inc.)
- Alex Granados
(Bioqual Inc.)
- Jack Greenhouse
(Bioqual Inc.)
- Michelle Walker
(Bioqual Inc.)
- Elinor Willis
(Perelman School of Medicine, University of Pennsylvania)
- Jae-Sung Yu
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Charles E. McGee
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Gregory D. Sempowski
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Barbara L. Mui
(Acuitas Therapeutics, Vancouver)
- Ying K. Tam
(Acuitas Therapeutics, Vancouver)
- Yan-Jang Huang
(Diagnostic Medicine and Pathobiology, College of Veterinary Medicine and the Biosecurity Research Institute, Kansas State University)
- Dana Vanlandingham
(Diagnostic Medicine and Pathobiology, College of Veterinary Medicine and the Biosecurity Research Institute, Kansas State University)
- Veronica M. Holmes
(Perelman School of Medicine, University of Pennsylvania)
- Harikrishnan Balachandran
(Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Sujata Sahu
(Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Michelle Lifton
(Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Stephen Higgs
(Diagnostic Medicine and Pathobiology, College of Veterinary Medicine and the Biosecurity Research Institute, Kansas State University)
- Scott E. Hensley
(Perelman School of Medicine, University of Pennsylvania)
- Thomas D. Madden
(Acuitas Therapeutics, Vancouver)
- Michael J. Hope
(Acuitas Therapeutics, Vancouver)
- Katalin Karikó
(BioNTech RNA Pharmaceuticals)
- Sampa Santra
(Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School)
- Barney S. Graham
(Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health)
- Mark G. Lewis
(Bioqual Inc.)
- Theodore C. Pierson
(Viral Pathogenesis Section, National Institute of Allergy and Infectious Disease, National Institutes of Health)
- Barton F. Haynes
(Duke Human Vaccine Institute, Duke University School of Medicine)
- Drew Weissman
(Perelman School of Medicine, University of Pennsylvania)
Abstract
A single, low-dose intradermal immunization with lipid-nanoparticle-encapsulated nucleoside-modified mRNA encoding the pre-membrane and envelope glycoproteins of Zika virus protects both mice and rhesus macaques against infection and elicits rapid and long-lasting neutralizing antibody responses.
Suggested Citation
Norbert Pardi & Michael J. Hogan & Rebecca S. Pelc & Hiromi Muramatsu & Hanne Andersen & Christina R. DeMaso & Kimberly A. Dowd & Laura L. Sutherland & Richard M. Scearce & Robert Parks & Wendeline Wa, 2017.
"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination,"
Nature, Nature, vol. 543(7644), pages 248-251, March.
Handle:
RePEc:nat:nature:v:543:y:2017:i:7644:d:10.1038_nature21428
DOI: 10.1038/nature21428
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:543:y:2017:i:7644:d:10.1038_nature21428. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.